Meanwhile, in caerulein-challenged FXRacinarΔ/Δ mice, GW4064 treatment lost the beneficial effects on pancreatitis (Figures 2(g)–2(i)), indicating that pancreatic acinar FXR is required for the therapeutic effects of GW4064 on AP. Here, NR1H4 is linked to pancreatitis.